Intra-Cellular Therapies, Inc. Gains 193.49%
Mon, Dec 23, 2019 at 05:30 PM
Intra-Cellular Therapies, Inc. (ITCI:NASDAQ) rocketted at $36.51, representing a gain of 193.5%. The stock appeared on our News Catalysts scanner on Mon 23 Dec 19 at 03:32 PM in the 'BIOTECH' category. From Mon 02 Dec 19, the stock recorded 57.14% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Intra-Cellular Therapies, Inc. (ITCI:NASDAQ)
Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders.
Top 10 Gainers:
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 193.49%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 83.03%
- China Finance Online Co. Limited (JRJC:NASDAQ), 78.35%
- Microbot Medical Inc. (MBOT:NASDAQ), 77.37%
- Cassava Sciences, Inc. (SAVA:NASDAQ), 59.56%
- Seadrill Limited (SDRL:NYSE), 38.46%
- Hexindai Inc. (HX:NASDAQ), 37.3%
- Cincinnati Bell Inc. (CBB:NYSE), 35.36%
- Cabaletta Bio, Inc. (CABA:NASDAQ), 33.86%
- Sienna Biopharmaceuticals, Inc. (SNNA:NASDAQ), 30.7%